Effects of neoadjuvant VEGF ‑TKI treatment on surgery for renal cell carcinoma: A systematic review and meta‑analysis

In conclusion, the results of the present study indicated that neoadjuvant VEGF-TKI treatment in patients with RCC shortened operation time, decreased blood loss and did not cause an increase in perioperative complications. In addition, this treatment modality may encourage patients to opt for partial nephrectomy to preserve renal function.PMID:38449796 | PMC:PMC10915807 | DOI:10.3892/ol.2024.14295

Source: Oncology Letters - March 7, 2024 Category: Cancer & Oncology Authors: Meikai Zhu Zhifeng Liu Yongheng Zhou Zhiwen Jiang Shouzhen Chen Wenfu Wang Benkang Shi Yaofeng Zhu Source Type: research